8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 6, 2009)

Filed August 6, 2009For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on August 6, 2009, to report its financial results for the quarter ended June 30, 2009. The report primarily consists of a press release announcing these results, which is furnished as an exhibit. Investors should note that while this 8-K provides an update on the company's financial condition for the period, the information contained within is considered 'furnished' rather than 'filed,' meaning it does not carry the same legal implications under Section 18 of the Exchange Act unless specifically incorporated into a future filing. This filing serves as a crucial notification to the market regarding ALNY's financial performance during the second quarter of 2009. Investors seeking detailed insights into the company's revenue, expenses, cash flow, and any forward-looking statements related to its drug development pipeline would need to consult the actual press release (Exhibit 99.1) referenced in the 8-K.

Key Highlights

  • 1Alnylam Pharmaceuticals announced its financial results for the second quarter ended June 30, 2009.
  • 2The results were disclosed via a press release furnished as Exhibit 99.1 to the 8-K filing.
  • 3The filing is dated August 6, 2009, indicating the timing of the financial update.
  • 4Information provided in this 8-K is furnished, not filed, under Section 18 of the Securities Exchange Act of 1934.
  • 5This report serves as a standard regulatory notification of quarterly financial performance.
  • 6Investors are directed to Exhibit 99.1 for the specific financial details and commentary.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce and provide Alnylam Pharmaceuticals, Inc.'s financial results for the quarter ended June 30, 2009. It includes a press release detailing these results.

The specific financial results and any accompanying commentary are contained within the press release, which is furnished as Exhibit 99.1 to this 8-K filing. Investors will need to review this exhibit for detailed information.

The information in this 8-K, including the furnished press release, is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, unless expressly incorporated by reference into a future filing. Therefore, it does not carry the same legal liabilities as a 'filed' document.

'Furnished' means the document is provided to the SEC for informational purposes but is not subject to the same liability provisions as 'filed' documents under Section 18 of the Exchange Act. 'Filed' documents are subject to greater regulatory scrutiny and potential liability for misstatements or omissions.